Search Results - "Lehmann, Lucine"

DEVOTE 3: temporal relationships between severe hypoglycaemia, cardiovascular outcomes and mortality by Pieber, Thomas R., Marso, Steven P., McGuire, Darren K., Zinman, Bernard, Poulter, Neil R., Emerson, Scott S., Pratley, Richard E., Woo, Vincent, Heller, Simon, Lange, Martin, Brown-Frandsen, Kirstine, Moses, Alan, Barner Lekdorf, Jesper, Lehmann, Lucine, Kvist, Kajsa, Buse, John B.

“…Aims/hypothesis The double-blind Trial Comparing Cardiovascular Safety of Insulin Degludec vs Insulin Glargine in Patients with Type 2 Diabetes at High Risk of…”
Get full text

The Efficacy of IDegLira (Insulin Degludec/Liraglutide Combination) in Adults with Type 2 Diabetes Inadequately Controlled with a GLP-1 Receptor Agonist and Oral Therapy: DUAL III Randomized Clinical Trial by Linjawi, Sultan, Bode, Bruce W., Chaykin, Louis B., Courrèges, Jean-Pierre, Handelsman, Yehuda, Lehmann, Lucine M., Mishra, Abhishek, Simpson, Richard W.

“…Introduction The progressive nature of type 2 diabetes necessitates treatment intensification. This often involves intensification with oral antidiabetic drugs…”
Get full text

Effect of Insulin Glargine Up-titration vs Insulin Degludec/Liraglutide on Glycated Hemoglobin Levels in Patients With Uncontrolled Type 2 Diabetes: The DUAL V Randomized Clinical Trial by Lingvay, Ildiko, Manghi, Federico Pérez, García-Hernández, Pedro, Norwood, Paul, Lehmann, Lucine, Tarp-Johansen, Mads Jeppe, Buse, John B

“…IMPORTANCE: Achieving glycemic control remains a challenge for patients with type 2 diabetes, even with insulin therapy. OBJECTIVE: To assess whether a fixed…”
Get full text

Evaluation of validity, reliability and ability to detect change for the Hand Eczema Severity Index (HECSI) and evaluation of HECSI-75 and HECSI-90 as within-patient responder definitions by Yüksel, Yasemin Topal, Thoning, Henrik, Larsen, Lotte Seiding, Lehmann, Lucine, Arbuckle, Rob, Grant, Laura, Agner, Tove

“…The Hand Eczema Severity Index (HECSI) is a Clinician-Reported Outcome measure of the severity of hand eczema (HE). This study aimed to evaluate the validity,…”
Get full text

Fixed‐ratio combination of insulin degludec and liraglutide (IDegLira) improves cardiovascular risk markers in patients with type 2 diabetes uncontrolled on basal insulin by Vilsbøll, Tina, Blevins, Thomas C., Jodar, Esteban, Poulter, Neil, Tentolouris, Nikolaos, Ross Agner, Bue F., Lehmann, Lucine, Leiter, Lawrence A.

“…In this post hoc analysis we investigated the effects of insulin degludec/liraglutide fixed‐ratio combination (IDegLira) versus comparators on cardiovascular…”
Get full text

Rates of hypoglycaemia are lower in patients treated with insulin degludec/liraglutide (IDegLira) than with IDeg or insulin glargine, regardless of the hypoglycaemia definition used by Norwood, Paul, Chen, Roger, Jaeckel, Elmar, Lingvay, Ildiko, Jarlov, Henrik, Lehmann, Lucine, Heller, Simon

“…Aims To re‐analyse, using a series of alternative hypoglycaemia definitions, the data from 2 trials, DUAL I and V, in which the once‐daily, fixed ratio…”
Get full text

Treatment of seasonal allergic rhinoconjunctivitis with a once-daily SQ-standardized grass allergy immunotherapy tablet by Nelson, Harold, Lehmann, Lucine, Blaiss, Michael S.

“…Abstract Objectives: Specific immunotherapy with the grass allergy immunotherapy tablet (AIT) has been developed as an effective, well tolerated, and…”
Get full text

23. Insulin Degludec/Liraglutide (IDegLira) Is Superior to Insulin Glargine (IG) in A1c Reduction, Risk of Hypoglycemia, and Weight Change: DUAL V Study (166-OR) by Buse, John B., Pérez Manghi, Federico C., García-Hernández, Pedro A., Norwood, Paul, Lehmann, Lucine, Tarp-Johansen, Mads Jeppe, Lingvay, Ildiko

Get full text